Volume 69, Issue 6 , Pages 278-281, June 2006
Invasive Pulmonary Aspergillosis with Cerebral Abscess in a Patient with Idiopathic Thrombocytopenic Purpura
Article Outline
Invasive aspergillosis is a devastating infection in immunocompromised hosts. The lung is the most common site of primary infection, and the central nervous system is the most common secondary site of invasive disease. Invasive aspergillosis in autoimmunopathies treated with corticosteroids has rarely been reported in the literature. Herein, we report the case of a 48-year-old female patient with idiopathic thrombocytopenic purpura complicated with fatal invasive pulmonary and cerebral aspergillosis. She had been given 1,016 g intravenous amphotericin B empirically for lung infection during a previous admission. At presentation, she had fever, cough, and shortness of breath for 4 weeks. Chest radiography revealed a huge cavity over the left upper lung field. Bronchoscopic biopsy and culture showed Aspergillus species. She was initially treated with intravenous amphotericin B (0.9 mg/kg/day), and intravenous hydrocortisone for her idiopathic thrombocytopenic purpura. However, deterioration of consciousness occurred 12 days after hospitalization. Computed tomography of the brain showed ring-like cystic mass lesions in the right side basal ganglion. Stereotactic aspiration of the brain revealed Aspergillus species. Her condition exacerbated despite combination treatment with high-dose amphotericin B (1.2 mg/kg/day) and itraconazole (400 mg/day). She died 24 days after admission. This case suggests that treatment with corticosteroids and premature discontinuation of antifungal drugs bear the risk of fatal cerebral involvement in patients with invasive pulmonary aspergillosis.
Key Words: brain abscess , idiopathic thrombocytopenic purpura , invasive pulmonary aspergillosis
No full text is available. To read the body of this article, please view the PDF online.
References
- . Disseminated aspergillosis involving the brain: distribution and imaging characteristics . AJNR Am J Neuroradiol . 1999;20:1597–1604
- Short-course corticosteroid-induced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura . Blood . 2001;98:2875–2877
- . Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopenia . Eur J Haematol . 2004;72:375–376
- . Two cases of cerebral aspergillosis successfully treated with voriconazole . Eur J Clin Microbiol Infect Dis . 2003;22:297–299
- . Therapeutic outcome in invasive aspergillosis . Clin Infect Dis . 1996;23:608–615
- . Nosocomial cerebral aspergillosis: a report of 3 cases . Scand J Infect Dis . 1996;28:317–319
- . Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia . Ann Intern Med . 1984;100:345–351
- . Fungal infections in chronic granulomatous disease: the importance of the phagocyte in defense against fungi . Am J Med . 1981;71:59–66
- . The spectrum of non-Candida fungal infections following bone marrow transplantation . Medicine (Baltimore) . 1993;72:78–89
- . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation . J Infect Dis . 1997;175:1459–1466
- . Clinical aspects of fungal infection in organ transplant recipients . Clin Infect Dis . 1994;19:33–40
- . Pulmonary aspergillosis in the acquired immunodeficiency syndrome . N Engl J Med . 1991;324:654–662
- . Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview . Eur Radiol . 2003;13:377–388
- . Invasive pulmonary aspergillosis in acute leukemia: the contribution of CT to early diagnosis and aggressive management . Chest . 1987;92:95–99
- . Air crescent sign of invasive aspergillosis . Radiology . 1979;133:17–21
- . Invasive pulmonary aspergillosis and acute leukemia: limitations in the diagnostic utility of the air crescent sign . Radiology . 1985;157:605–610
- . Value of antigen detection in predicting invasive pulmonary aspergillosis . Lancet . 1990;336:1210–1213
- Practice guidelines for diseases caused by Aspergillus . Clin Infect Dis . 2000;30:696–709
- . Combination antifungal therapy . Antimicrob Agents Chemother . 2004;48:693–715
- Voriconazole versus am-photericin B for primary therapy of invasive aspergillosis . N Engl J Med . 2002;347:408–415
- . Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients . Clin Infect Dis . 2003;37:728–732
- . Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia . Br J Haematol . 1997;97:663–665
PII: S1726-4901(09)70257-6
doi:10.1016/S1726-4901(09)70257-6
© 2006 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 69, Issue 6 , Pages 278-281, June 2006
